NCT06207370View on ClinicalTrials.gov

Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

July 1, 2025

Conditions
Babesiosis
Interventions
DRUG

Tafenoquine

Oral Tafenoquine

OTHER

Placebo

Placebo

Trial Locations (1)

02111

RECRUITING

Tufts Medical Center, Boston

Sponsors
All Listed Sponsors
lead

60 Degrees Pharmaceuticals LLC

INDUSTRY

NCT06207370 - Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis | Biotech Hunter | Biotech Hunter